The American College of Lifestyle Medicine (ACLM) has published the first clinical practice guideline to put lifestyle interventions at the forefront of type 2 diabetes and prediabetes care.

Statistics indicate that type 2 diabetes (T2D) affects approximately 14% of the global population. This is significant ...

The new guideline is unique because it is the first with clear, practical, and evidence-based strategies on how people with prediabetes or type 2 diabetes can optimize their lifestyle behaviors, ...

The American College of Lifestyle Medicine has published the first clinical practice guideline focusing primarily on lifestyle interventions for diabetes treatment and potential remission of type 2 ...

Reaching type 2 diabetes remission is a major milestone. Remission means maintaining a hemoglobin A1C status of below 6.5 percent for at least three months without taking any glucose-lowering ...

Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published online June 26 in JAMA Network Open. Daniel ...

Endocrinologists offer updated recommendations to increase glycemic control and avoid complications. Here is a quick summary. The American Association of Clinical Endocrinologists (AACE) has released ...

Type 2 diabetes (T2D) is the most common form of diabetes, representing more than 90% of all cases worldwide. The prevalence of T2D is increasing globally, mainly because of behavioral and social ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...